Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID-19) patients: an observational study
Int Forum Allergy Rhinol
.
2021 Dec;11(12):1689-1693.
doi: 10.1002/alr.22848.
Epub 2021 Jun 16.
Authors
Luca Giovanni Locatello
1
,
Benedetta Trotta
1
,
Chiara Bruno
1
,
Michele Trotta
2
,
Giandomenico Maggiore
1
,
Laura Rasero
3
,
Saverio Caini
4
,
Oreste Gallo
1
5
Affiliations
1
Department of Otorhinolaryngology, Careggi University Hospital, Florence, Italy.
2
Department of Infectious and Tropical Diseases, Careggi University Hospital, Florence, Italy.
3
Department of Health Sciences, University of Florence, Florence, Italy.
4
Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
5
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
PMID:
34132052
PMCID:
PMC8427029
DOI:
10.1002/alr.22848
No abstract available
Keywords:
COVID-19; prognosis; recovery; smell; steroids; taste.
Publication types
Observational Study
MeSH terms
Anosmia
COVID-19*
Humans
Olfaction Disorders* / drug therapy
SARS-CoV-2
Smell
Steroids / therapeutic use
Taste
Substances
Steroids